Page last updated: 2024-08-22

poloxalene and Anemia, Sickle Cell

poloxalene has been researched along with Anemia, Sickle Cell in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Embury, SH1
Adams-Graves, P; Bustrack, J; Crawford, R; Edwards, S; Emanuele, M; Kedar, A; Koshy, M; Steinberg, M; Veith, R; Ward, D1
Clawson, CC; Hebbel, RP; Smith, CM; Tukey, DP; Vercellotti, GM; White, JG1

Trials

1 trial(s) available for poloxalene and Anemia, Sickle Cell

ArticleYear
RheothRx (poloxamer 188) injection for the acute painful episode of sickle cell disease: a pilot study.
    Blood, 1997, Sep-01, Volume: 90, Issue:5

    Topics: Adolescent; Adult; Anemia, Sickle Cell; Double-Blind Method; Female; Fibrinolytic Agents; Humans; Infusions, Intravenous; Male; Pain; Pilot Projects; Poloxalene

1997

Other Studies

2 other study(ies) available for poloxalene and Anemia, Sickle Cell

ArticleYear
New treatments of sickle cell disease.
    The Western journal of medicine, 1996, Volume: 164, Issue:5

    Topics: Anemia, Sickle Cell; Antisickling Agents; Blood Transfusion; Bone Marrow Transplantation; Genetic Therapy; Humans; Hydroxyurea; Poloxalene

1996
Pluronic F-68 reduces the endothelial adherence and improves the rheology of liganded sickle erythrocytes.
    Blood, 1987, Volume: 69, Issue:6

    Topics: Adult; Anemia, Sickle Cell; Blood Substitutes; Cell Adhesion; Child; Child, Preschool; Endothelium; Erythrocyte Aggregation; Erythrocyte Deformability; Humans; Poloxalene; Polyethylene Glycols; Rheology

1987